Key points are not available for this paper at this time.
Design
Editorial
Highlights the severe underfunding of international aid for essential malaria treatments like artemisinin-based combination therapies.
About $1bn a year of new international aid will pay for artemisinin based combination therapies for around 60% of those who need it. 7 Yet researchers at Harvard estimated that total international aid for malaria control in 2000 was just $100m. 8 Although annual spending on malaria has increased since then as a result of the creation of the Global Fund-for example, the fund had disbursed $37.3m to malaria programmes as of 23 October 2003 (Jon Liden, personal communication, 2004)-this is still nowhere near the amount that is needed. Some donors, like the United States Agency for International Development, spend nothing at all on malaria drugs. Unicef spent just $1m in 2003 on procuring artemisinin based treatments.
No takes yet. Share an insight, caveat, or question.
Roger M. Greenhalgh (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: